Joseph K, Höffken H, Bosslet K, Schorlemmer H U
Department of Clinical Nuclear Medicine, Philipps University, Marburg, FRG.
Nucl Med Commun. 1988 Oct;9(10):763-9. doi: 10.1097/00006231-198810000-00013.
We have looked for inflammatory lesions in 37 patients using granulocytes labelled in vivo. For the purpose of cell labelling we used a monoclonal murine antibody reacting with NCA and carcinoembryonic antigen (CEA) (BW 250/183) labelled with 99Tcm. All abscesses and other inflammatory lesions were visualized with excellent quality scintigrams between 2 and 6 h after the injection. As the antibody can be stored in a freeze-dried form and labelled at any time in any department of nuclear medicine with 99Tcm without cell separation being necessary, the method appears to be suitable even for use in acute diagnosis. No side effects have so far been found.
我们使用体内标记的粒细胞对37例患者进行了炎性病变的检测。为了进行细胞标记,我们使用了一种与NCA和癌胚抗原(CEA)反应的单克隆鼠抗体(BW 250/183),并用99Tcm进行标记。所有脓肿及其他炎性病变在注射后2至6小时内均能通过高质量的闪烁扫描图清晰显示。由于该抗体可以冻干形式保存,且无需细胞分离,在核医学的任何科室均可随时用99Tcm进行标记,因此该方法似乎甚至适用于急性诊断。迄今为止尚未发现任何副作用。